The EPA issued guidelines for carcinogen risk assessment, replacing previous versions. These guidelines emphasize critical analysis of available data, mode of action, weight of evidence, and dose-response assessment. They provide a framework for evaluating carcinogenic risks, including hazard identification, dose-response assessment, exposure assessment, and risk characterization. The guidelines stress the importance of considering susceptible populations and life stages, particularly children, and the potential for early-life exposure to increase cancer risk. They also address the use of default options when data are insufficient, and encourage the use of peer-reviewed scientific information. The guidelines emphasize the need for consistency in risk assessment procedures while allowing for flexibility in incorporating new scientific findings. They also highlight the importance of considering the biological mechanisms of carcinogens, such as direct DNA reactivity or indirect DNA effects, and the role of toxicokinetic and toxicodynamic modeling in dose-response assessment. The guidelines also address the need for clear communication of risk assessments to the public and decision-makers, including the presentation of point estimates and statistical bounds. The guidelines are intended as guidance only and do not establish binding rules. They are designed to ensure that risk assessments are based on the best available science and are consistent with the EPA's mission to protect human health and the environment. The guidelines also emphasize the importance of considering the potential for early-life exposure to increase cancer risk and the need for special attention to children and other susceptible populations. The guidelines encourage the use of a tiered approach to risk assessment, considering available data and the potential for differential risk based on life stage. They also recommend the use of linear low-dose extrapolation methods when data are insufficient, and encourage the development of additional guidance for other modes of action as needed.The EPA issued guidelines for carcinogen risk assessment, replacing previous versions. These guidelines emphasize critical analysis of available data, mode of action, weight of evidence, and dose-response assessment. They provide a framework for evaluating carcinogenic risks, including hazard identification, dose-response assessment, exposure assessment, and risk characterization. The guidelines stress the importance of considering susceptible populations and life stages, particularly children, and the potential for early-life exposure to increase cancer risk. They also address the use of default options when data are insufficient, and encourage the use of peer-reviewed scientific information. The guidelines emphasize the need for consistency in risk assessment procedures while allowing for flexibility in incorporating new scientific findings. They also highlight the importance of considering the biological mechanisms of carcinogens, such as direct DNA reactivity or indirect DNA effects, and the role of toxicokinetic and toxicodynamic modeling in dose-response assessment. The guidelines also address the need for clear communication of risk assessments to the public and decision-makers, including the presentation of point estimates and statistical bounds. The guidelines are intended as guidance only and do not establish binding rules. They are designed to ensure that risk assessments are based on the best available science and are consistent with the EPA's mission to protect human health and the environment. The guidelines also emphasize the importance of considering the potential for early-life exposure to increase cancer risk and the need for special attention to children and other susceptible populations. The guidelines encourage the use of a tiered approach to risk assessment, considering available data and the potential for differential risk based on life stage. They also recommend the use of linear low-dose extrapolation methods when data are insufficient, and encourage the development of additional guidance for other modes of action as needed.